We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Chiron Acquires Prion Solutions

By HospiMedica staff writers
Posted on 12 Sep 2004
In a move that complements its own research efforts, Chiron Corp. (Emeryville, CA, USA) has acquired Prion Solutions, Inc. (La Jolla, CA, USA). Financial details were not disclosed.

Prion Solutions is focused on research into variant Creutzfeldt-Jakob disease (vCJD) and other prion-related diseases. The company holds exclusive rights from Scripps Institute to an antibody that recognizes the disease-specific form of the cellular prion protein. This technology from Prion Solutions complements Chiron's existing research on prions, which has been successful in identifying several classes of reagents that bind specifically to the disease-related form of prions and are useful for development of a blood-screening assay.

Cases of vCJD recorded in Europe have been linked to eating or contact with cattle infected with bovine spongiform encephalopathy, or mad-cow disease. The disease is a slow, progressive disease of the central nervous system, believed to be caused by an infectious prion, a protein particle. Two cases have been reported where blood from a donor who was later identified to have vCJD was transfused to a patient who later developed vCJD, suggesting the possibility that vCJD can be transmitted through transfusion.

Chiron blood testing is dedicated to preventing the spread of infectious diseases through the development of novel blood-screening tools that protect the world blood supply. These include the company's Procleix assay and systems that use nucleic acid testing (NAT) technology to detect RNA and DNA in donated blood, plasma, organs, and tissue during the very early stages of infection, when infectious agents are present but cannot be detected by immunodiagnostic screening technologies.

"The technology developed by Prion Solutions complements our program and will advance the development of a highly sensitive and specific test to screen blood donations for cVJD, which is believed to be transmissible through blood,” explained Jack Goldstein, president, Chiron Blood Testing.




Related Links:
Chiron

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
LED Examination Lamp
Clarity 50 LED
New
Mobile Power Procedure Chair
LeMans P360

Latest Business News

Boston Scientific Acquires Medical Device Company Intera Oncology

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024